3 Key Considerations for Implementing Biosimilars in Health Systems

The Center for Biosimilars

In this article, Rick Lozano, vice president of biosimilars and integrated business development for AmerisourceBergen, shares the three considerations for implementing biosimilars in the health system setting.

More in the Media

Specialty Pharmacy Times

Patient-Centered Care The Case for Site Expansion to Include Health System Specialty Pharmacy

October 31, 2018

Becker's Hospital Review

Supply chain tip of the day: Invest in professional development for your pharmacy staff

October 11, 2018

Becker's Hospital Review

Supply chain tip of the day: Establish a specialty pharmacy strategy to improve operations, patient care

October 04, 2018

Drug Channels

It’s Time to Rethink Channel Strategy for Oral Oncolytics

September 21, 2018